Table 1.
Characteristic | Value |
Total no. of diabetic patients registered | 4,404 |
Type of diabetes, n (%): | |
Type 1 | 54 (1.2%) |
Type 2 | 4,350 (98.8%) |
Age in years, median (IQR) | 53 (46 to 60) |
Age group in years, n (%): | |
≥39 | 438 (10.0%) |
40 to 49 | 1,168 (26.5%) |
50 to 59 | 1,540 (35.0%) |
≥60 | 1,258 (28.6%) |
Women, n(%) | 2,905 (66.0%) |
Origin of patients*, n (%): | |
District of clinic | 1,724 (41.2%) |
Other districts of province | 1,550 (37.0%) |
Outside province | 912 (21.8%) |
Random plasma glucose on admission, median (IQR) | 272 (196 to 376) |
Random plasma glucose <180 mg/dl, n (%) | 797/4,095 (19.5%) |
HbA1c on admission %, median (IQR) (n = 950) | 11.5 (9.1 to 13.5) |
HbA1c <7%, n (%) | 59/950 (6.2%) |
Blood pressure on admission, n (%): | |
Systolic ≥140 mm Hg | 1,555/3,840 (40.5%) |
Diastolic ≥90 mm Hg | 1,316/3,840 (34.3%) |
BMI on admission, kg/m2, median (IQR) (n = 4337): | |
All patients | 23.5 (20.9 to 26) |
Men | 23 (20.1 to 26) |
Women | 23.7 (21.1 to 26.2) |
BMI ≥23 kg/m2, n (%) | 2,433/4,337 (56.1%) |
BMI ≥27.5 kg/m2, n (%) | 686/4,337 (15.8%) |
Treatment on last consultation, n (%): | |
No antidiabetic drug | 91 (2.2%) |
Oral antidiabetic drug(s) alone | 3,911 (94.1%) |
Insulin alone | 115 (2.8%) |
Oral antidiabetic drug(s) plus insulin | 41 (1.0%) |
No data | 246 |
*Data on origin available only for patients admitted until February 2008.
BMI = body mass index; HbA1c = glycosylated hemoglobin; IQR = interquartile range.